Thursday, April, 18, 2019 08:35:29

Contribution By Ojaswita Kutepatil


Innovent, Chipscreen Biosciences team up on colorectal cancer therapy

Shenzhen Chipscreen Biosciences Ltd., a leading China-based integrated biotech company, has reportedly entered into a collaboration agreement with Innovent Biologics Inc., a Chinese development-stage biopharmaceutical company, in a major effort to evaluate the tolerability and safety of the combination therapy involving Innovent’s Sintilimab and Chipscreen’s …

AbCellera to sign multi-target partnership deal with Novartis

AbCellera Biologics Inc., the antibody therapeutics developer based in Vancouver, has reportedly entered into a multi-year, multi-target partnership agreement with Novartis International AG, the Swiss multinational pharmaceutical company. Reportedly, the agreement entails the identification of antibodies for about ten therapeutic targets in the pipeline of …

GrapheneCA plans graphene production for cosmetics & pharma sectors

Nano Graphene Inc. (also known as GrapheneCA), a US-based supplier of graphene-based materials, has reportedly announced its plans to make graphene readily available for use in the cosmetics and pharmaceutical industries. Reportedly, GrapheneCA’s latest move helps in paving the path for the introduction & licensing …